SkinHealth Systems Inc. Class A (SKIN)

In the past six months, SkinHealth Systems' stock has been affected by several events. The company rebranded in April 2026, aiming for a clinically driven platform. The Q1 2026 earnings report in May 2026 showed net sales of $64.9 million, a 6.7% year-over-year decrease, but adjusted EBITDA rose 17% to $8.5 million. The company lowered its full-year 2026 net sales guidance but maintained its adjusted EBITDA guidance. Three new independent directors were appointed to the Board in April/May 2026. The stock price has been volatile, declining 24.27% over the past year as of May 1, 2026.

The provided search results do not contain explicit information about the demand seasonality for SkinHealth Systems, Inc. products and services. The company operates in the medical aesthetics and personal care products industry, which can sometimes experience seasonal fluctuations related to holidays, consumer spending habits, and aesthetic treatment trends. Recent financial reports indicate challenging market conditions and softer device placements, suggesting that demand may be influenced by broader economic factors rather than clear seasonal patterns.

SkinHealth Systems, Inc. (SKIN), formerly The Beauty Health Company, is a global medical aesthetics company focused on designing, developing, manufacturing, marketing, and selling aesthetic technologies and products. The company rebranded in April 2026 to emphasize a clinically driven, science-backed approach. Its flagship product is HydraFacial, a hydradermabrasion treatment, and it offers a range of solutions including Syndeo devices, consumables, SkinStylus SteriLock Microsystem, and Keravive peptide solutions, along with the MyBeautyHealth mobile application.

SkinHealth Systems has a global presence across the Americas, Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. It maintains commercial operations in North America, Europe, and Asia-Pacific, with over 36,000 devices installed worldwide. Consumables are the top-performing segment, and the Americas contribute the most to revenue. In Q2 2025, the company transitioned sales in China to a distributor partner.

SkinHealth Systems' brand reputation has been influenced by its rebranding and market challenges. The transition to SkinHealth Systems Inc. aimed to position the company as a clinically driven platform. However, the rebranding carries risks related to brand recognition, customer loyalty, and marketing costs. HydraFacial remains the flagship product, and management emphasizes its strength and the growing installed base for future growth.

SkinHealth Systems Inc. has significant institutional ownership, with 120 institutional owners holding 62.50% of the company's shares, while insiders own about 57.58%. Major institutional owners include Capricorn Fund Managers Ltd, Mirabella Financial Services Llp, Fmr Llc, BlackRock, Inc., Millennium Management Llc, and Vanguard Group Inc. Significant individual and insider owners include Lcp Edge Holdco LLC (26.11% ownership), Brent L. Saunders (15.89% ownership), Pedro Bruno Ferreira Malha (CEO), and Marla Malcolm Beck.